HELIAD AG (A7A.DE) Fundamental Analysis & Valuation

FRA:A7A • DE0001218063

Current stock price

13.7 EUR
0 (0%)
Last:

This A7A.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. A7A.DE Profitability Analysis

1.1 Basic Checks

  • A7A had positive earnings in the past year.
  • The reported net income has been mixed in the past 5 years: A7A reported negative net income in multiple years.
  • In the past 5 years A7A reported 4 times negative operating cash flow.
A7A.DE Yearly Net Income VS EBIT VS OCF VS FCFA7A.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.82%, A7A is in the better half of the industry, outperforming 64.17% of the companies in the same industry.
  • The Return On Equity of A7A (3.59%) is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 1.67%, A7A is in line with its industry, outperforming 55.00% of the companies in the same industry.
Industry RankSector Rank
ROA 2.82%
ROE 3.59%
ROIC 1.67%
ROA(3y)-3.65%
ROA(5y)-2.19%
ROE(3y)-4.7%
ROE(5y)-2.82%
ROIC(3y)N/A
ROIC(5y)N/A
A7A.DE Yearly ROA, ROE, ROICA7A.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

  • Looking at the Profit Margin, with a value of 519.85%, A7A belongs to the top of the industry, outperforming 99.17% of the companies in the same industry.
  • In the last couple of years the Profit Margin of A7A has declined.
  • The Operating Margin of A7A (431.95%) is better than 100.00% of its industry peers.
  • A7A's Operating Margin has improved in the last couple of years.
  • A7A's Gross Margin of 93.38% is amongst the best of the industry. A7A outperforms 94.17% of its industry peers.
  • A7A's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 431.95%
PM (TTM) 519.85%
GM 93.38%
OM growth 3Y132.69%
OM growth 5Y55.14%
PM growth 3YN/A
PM growth 5Y-11.53%
GM growth 3Y-0.25%
GM growth 5YN/A
A7A.DE Yearly Profit, Operating, Gross MarginsA7A.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

3

2. A7A.DE Health Analysis

2.1 Basic Checks

  • A7A has about the same amout of shares outstanding than it did 1 year ago.
  • A7A has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, A7A has a worse debt to assets ratio.
A7A.DE Yearly Shares OutstandingA7A.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
A7A.DE Yearly Total Debt VS Total AssetsA7A.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

  • An Altman-Z score of 4.48 indicates that A7A is not in any danger for bankruptcy at the moment.
  • A7A has a better Altman-Z score (4.48) than 87.50% of its industry peers.
  • A7A has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
  • A7A's Debt to Equity ratio of 0.24 is fine compared to the rest of the industry. A7A outperforms 71.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z 4.48
ROIC/WACCN/A
WACCN/A
A7A.DE Yearly LT Debt VS Equity VS FCFA7A.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.3 Liquidity

  • A7A has a Current Ratio of 0.57. This is a bad value and indicates that A7A is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A7A has a Current ratio (0.57) which is comparable to the rest of the industry.
  • A Quick Ratio of 0.57 indicates that A7A may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.57, A7A perfoms like the industry average, outperforming 47.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.57
A7A.DE Yearly Current Assets VS Current LiabilitesA7A.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

3

3. A7A.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 114.16% over the past year.
  • Measured over the past years, A7A shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -46.21% on average per year.
  • The Revenue for A7A has decreased by -40.16% in the past year. This is quite bad
  • A7A shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -33.67% yearly.
EPS 1Y (TTM)114.16%
EPS 3YN/A
EPS 5Y-46.21%
EPS Q2Q%144.44%
Revenue 1Y (TTM)-40.16%
Revenue growth 3Y-52.27%
Revenue growth 5Y-33.67%
Sales Q2Q%611.32%

3.2 Future

  • A7A is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.41% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y200%
EPS Next 2Y73.21%
EPS Next 3Y44.23%
EPS Next 5Y31.41%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
A7A.DE Yearly Revenue VS EstimatesA7A.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1M 2M 3M 4M 5M
A7A.DE Yearly EPS VS EstimatesA7A.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2023 2024 2025 2026 2027 2028 2 4 6

3

4. A7A.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 41.52, which means the current valuation is very expensive for A7A.
  • A7A's Price/Earnings ratio is in line with the industry average.
  • A7A is valuated expensively when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 22.75, A7A is valued on the expensive side.
  • A7A's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 23.83. A7A is around the same levels.
Industry RankSector Rank
PE 41.52
Fwd PE 22.75
A7A.DE Price Earnings VS Forward Price EarningsA7A.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
A7A.DE Per share dataA7A.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • A7A's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A7A's earnings are expected to grow with 44.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y73.21%
EPS Next 3Y44.23%

0

5. A7A.DE Dividend Analysis

5.1 Amount

  • No dividends for A7A!.
Industry RankSector Rank
Dividend Yield 0%

A7A.DE Fundamentals: All Metrics, Ratios and Statistics

HELIAD AG

FRA:A7A (3/13/2026, 7:00:00 PM)

13.7

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)09-30
Earnings (Next)04-30
Inst Owners0.73%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap123.44M
Revenue(TTM)529.00K
Net Income(TTM)2.75M
Analysts80
Price Target24.53 (79.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 41.52
Fwd PE 22.75
P/S 233.34
P/FCF N/A
P/OCF N/A
P/B 1.61
P/tB 1.61
EV/EBITDA N/A
EPS(TTM)0.33
EY2.41%
EPS(NY)0.6
Fwd EY4.4%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.06
BVpS8.5
TBVpS8.5
PEG (NY)0.21
PEG (5Y)N/A
Graham Number7.94
Profitability
Industry RankSector Rank
ROA 2.82%
ROE 3.59%
ROCE 2.93%
ROIC 1.67%
ROICexc 1.79%
ROICexgc 1.79%
OM 431.95%
PM (TTM) 519.85%
GM 93.38%
FCFM N/A
ROA(3y)-3.65%
ROA(5y)-2.19%
ROE(3y)-4.7%
ROE(5y)-2.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-8.62%
ROICexgc growth 5Y12.14%
ROICexc growth 3Y-8.62%
ROICexc growth 5Y12.14%
OM growth 3Y132.69%
OM growth 5Y55.14%
PM growth 3YN/A
PM growth 5Y-11.53%
GM growth 3Y-0.25%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.57
Altman-Z 4.48
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.16%
EPS 3YN/A
EPS 5Y-46.21%
EPS Q2Q%144.44%
EPS Next Y200%
EPS Next 2Y73.21%
EPS Next 3Y44.23%
EPS Next 5Y31.41%
Revenue 1Y (TTM)-40.16%
Revenue growth 3Y-52.27%
Revenue growth 5Y-33.67%
Sales Q2Q%611.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y454.81%
EBIT growth 3Y11.06%
EBIT growth 5Y2.9%
EBIT Next Year-100%
EBIT Next 3Y22.99%
EBIT Next 5Y17.05%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

HELIAD AG / A7A.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HELIAD AG (A7A.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to A7A.DE.


What is the valuation status of HELIAD AG (A7A.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to HELIAD AG (A7A.DE). This can be considered as Overvalued.


What is the profitability of A7A stock?

HELIAD AG (A7A.DE) has a profitability rating of 5 / 10.


What is the valuation of HELIAD AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for HELIAD AG (A7A.DE) is 41.52 and the Price/Book (PB) ratio is 1.61.


What is the expected EPS growth for HELIAD AG (A7A.DE) stock?

The Earnings per Share (EPS) of HELIAD AG (A7A.DE) is expected to grow by 200% in the next year.